Furthermore, ILC2s in bronchoalveolar lavage fluid with high levels of TSLP were found to be steroid-resistant, suggesting that the TSLP/ILC2 axis is an important therapeutic target that is not responsive to inhaled corticosteroids, the gold standard in asthma therapy [58]. The gene discussed is TSLP; the disease is asthma.